Although clinical trials of Oncorine for human melanoma have not yet been performed, Hu and colleagues found evidence that the use of ZD55-IL-24 (similar to Oncorine) in an animal model of melanoma prevents tumor growth and induced systemic antitumor immunity (Hu et al., 2020). The gene discussed is IL24; the disease is melanoma.